Vaccine Hesitancy and COVID-19: Considerations for Communication
Source
International Vaccine Access Center, Johns Hopkins Bloomberg School of Public HealthThis presentation presents the issues we confront in deciding how to communicate to the public that COVID-19 vaccine recommendations reflect the state of scientific knowledge.
Within the COVID-19 context, vaccine hesitancy is driven by several issues in the mindset of some members of the public that the government is over-reaching and that the scientists don't know enough to do their jobs. Much of this distrust comes from misinformation in the media.
The presentation also lists principles of risk communication:
- Be first
- Be right
- Promote action
Another two questions are posed:
- How should practitioners communicate to caregivers?
- How should we communicate for acceptance?
- Interpersonal Communication for Immunization (IPC-I)
- 5 Ways to Use Sensitivity When Writing About Vaccines
- Behavioural Considerations for Acceptance and Uptake of COVID-19 Vaccines: WHO Technical Advisory Group on Behavioural Insights and Sciences for Health
- COVID-19 Vaccination Communication
- Guidance on Developing a National Deployment and Vaccination Plan for COVID-19 Vaccines
- COVID-19: Can Behavior Insights Address Vaccine Hesitancy and Increase Take-up?
- Vaccine Hesitancy in Low- and Middle-income Countries: Potential Implications for the COVID-19 Response
- Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy
- Framework for Decision-making: Implementation of Mass Vaccination Campaigns in the Context of COVID-19
- Vaccine Confidence Project
Last Updated
January 6, 2021
